Literature DB >> 17090777

The clinical and immunological features of leprosy.

S L Walker1, D N J Lockwood.   

Abstract

Leprosy is a granulomatous disease affecting the skin and nerves caused by Mycobacterium leprae. It continues to be a significant public health problem. Multidrug therapy (MDT) cures the infection, but immunological reactions may occur and neuropathy may lead to disability and deformity. It is important that the manifestations of the condition are recognized as early as possible so that early nerve damage can be identified and treated rapidly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090777     DOI: 10.1093/bmb/ldl010

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  44 in total

Review 1.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

2.  Borderline tuberculoid leprosy with type 1/reversal reaction.

Authors:  Supriya Khardenavis; Anirudda Deshpande
Journal:  BMJ Case Rep       Date:  2014-01-30

3.  Murine experimental leprosy: Evaluation of immune response by analysis of peritoneal lavage cells and footpad histopathology.

Authors:  Fátima Regina Vilani-Moreno; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Suzana Madeira Diório; Sônia Maria Usó Ruiz Silva; Patrícia Sammarco Rosa; Andréa de Faria Fernandes Belone; Cleverson Teixeira Soares; José Roberto Pereira Lauris; Sílvia Cristina Barboza Pedrini
Journal:  Int J Exp Pathol       Date:  2019-05-24       Impact factor: 1.925

4.  Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.

Authors:  Sundeep Chaitanya; Mallika Lavania; Ravindra P Turankar; Samuel Raj Karri; U Sengupta
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

Review 5.  Endocrine dysfunction in leprosy.

Authors:  A M O Leal; N T Foss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-16       Impact factor: 3.267

6.  Indeterminate leprosy and lepromatous index case: four cases in the same family.

Authors:  Vanessa Priscilla Martins da Silva; Heloisa Helena Ramos Fonseca; Mariana Mazzochi Sens; Alvaro Thadeu Bender
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

7.  Case Report: Leprosy Osteoarticular Alterations Mimicking Rheumatoid Arthritis.

Authors:  Rachel Bertolani do Espírito Santo; Rachel A Serafim; Jurama Barros Gueiros Bitran; Simon M Collin; Patrícia Deps
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

8.  A report of rifampin-resistant leprosy from northern and eastern India: identification and in silico analysis of molecular interactions.

Authors:  Sundeep Chaitanya Vedithi; Mallika Lavania; Manoj Kumar; Punit Kaur; Ravindra P Turankar; Itu Singh; Astha Nigam; Utpal Sengupta
Journal:  Med Microbiol Immunol       Date:  2014-09-09       Impact factor: 3.402

9.  Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss.

Authors:  Carlos Franco-Paredes; Jesse T Jacob; Barbara Stryjewska; Leo Yoder
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

10.  A Study on the Impact of Genetic Polymorphisms of Cytokines TNFα, IFNγ and IL10 in South Indian Leprosy Patients.

Authors:  Venkata Karunakar Kolla; Shehnaz Sultana; Samuel Abraham Joshi Davala; Vijaya Lakshmi Valluri
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.